Christianson John C, Engber William, Andes David
Department of Medicine, Division of Infectious Diseases, University of Wisconsin Hospital and Clinics, Madison, Wisconsin 53792-5158, USA.
Med Mycol. 2003 Jun;41(3):177-88. doi: 10.1080/1369378031000137224.
A case of primary cutaneous cryptococcal infection is presented and cases of primary cutaneous cryptococcosis in normal and immunocompromised hosts are reviewed. Cutaneous cryptococcosis can occur from local inoculation or dissemination from a distant site of infection. Risk factors associated with development of primary cutaneous cryptococcosis are those which affect cell-mediated immunity, such as corticosteroid usage, solid organ transplantation, sarcoidosis and immunosuppression. The cutaneous manifestations of cryptococcosis are protean and may mimic other cutaneous diseases. Patients with a diagnosis of cryptococcosis from a skin biopsy or culture should undergo evaluation to exclude disseminated disease and an evaluation of cell-mediated immunity. Although some patients do well without antifungal therapy, these patients cannot be discerned prospectively and therefore antifungal therapy appears warranted in all patients with localized disease. Choice of therapy depends on the extent of disease and immunocompetence of the host.
本文报告了一例原发性皮肤隐球菌感染病例,并对正常宿主和免疫功能低下宿主中的原发性皮肤隐球菌病病例进行了综述。皮肤隐球菌病可由局部接种或远处感染部位播散引起。与原发性皮肤隐球菌病发生相关的危险因素是那些影响细胞介导免疫的因素,如使用皮质类固醇、实体器官移植、结节病和免疫抑制。隐球菌病的皮肤表现多种多样,可能与其他皮肤病相似。经皮肤活检或培养诊断为隐球菌病的患者应进行评估,以排除播散性疾病,并评估细胞介导免疫。虽然一些患者在不进行抗真菌治疗的情况下病情良好,但无法前瞻性地识别这些患者,因此所有局限性疾病患者似乎都有必要接受抗真菌治疗。治疗方案的选择取决于疾病的程度和宿主的免疫功能。